| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peritoneal Dialysis | 10 | 2022 | 30 | 4.220 |
Why?
|
| Muscle, Smooth, Vascular | 26 | 2014 | 317 | 3.530 |
Why?
|
| Angiotensin II | 22 | 2013 | 220 | 2.380 |
Why?
|
| Kidney Failure, Chronic | 9 | 2022 | 365 | 2.240 |
Why?
|
| Receptors, Angiotensin | 16 | 2016 | 59 | 1.940 |
Why?
|
| Receptor, Angiotensin, Type 1 | 7 | 2014 | 80 | 1.900 |
Why?
|
| Peritonitis | 4 | 2022 | 46 | 1.850 |
Why?
|
| Renal Dialysis | 7 | 2016 | 174 | 1.360 |
Why?
|
| Cyclooxygenase 2 | 4 | 2014 | 160 | 1.140 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2013 | 144 | 1.040 |
Why?
|
| Nephrology | 2 | 2017 | 43 | 0.980 |
Why?
|
| Aorta | 7 | 2014 | 316 | 0.930 |
Why?
|
| Hypokalemia | 1 | 2022 | 12 | 0.860 |
Why?
|
| Hyperkalemia | 1 | 2022 | 21 | 0.850 |
Why?
|
| Cultural Competency | 1 | 2022 | 42 | 0.820 |
Why?
|
| Professional-Patient Relations | 1 | 2022 | 71 | 0.810 |
Why?
|
| Aldosterone | 7 | 2003 | 51 | 0.770 |
Why?
|
| Rats | 34 | 2014 | 5300 | 0.700 |
Why?
|
| Communication | 1 | 2022 | 329 | 0.690 |
Why?
|
| Vasoconstriction | 5 | 1999 | 81 | 0.590 |
Why?
|
| Peritoneal Fibrosis | 1 | 2016 | 2 | 0.550 |
Why?
|
| Drug and Narcotic Control | 1 | 2016 | 15 | 0.540 |
Why?
|
| Postal Service | 1 | 2016 | 19 | 0.540 |
Why?
|
| Pharmacies | 1 | 2016 | 18 | 0.540 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 282 | 0.520 |
Why?
|
| House Calls | 1 | 2015 | 15 | 0.520 |
Why?
|
| Nurses | 1 | 2016 | 53 | 0.510 |
Why?
|
| Motor Vehicles | 1 | 2015 | 20 | 0.510 |
Why?
|
| Clathrin | 1 | 2014 | 17 | 0.500 |
Why?
|
| Kidney Diseases | 2 | 2010 | 307 | 0.470 |
Why?
|
| Blood Pressure | 6 | 2005 | 1451 | 0.450 |
Why?
|
| Cells, Cultured | 17 | 2013 | 2673 | 0.450 |
Why?
|
| Animals | 41 | 2016 | 20881 | 0.440 |
Why?
|
| Citrate (si)-Synthase | 3 | 2003 | 11 | 0.430 |
Why?
|
| Kidney | 4 | 2010 | 945 | 0.430 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2013 | 2083 | 0.430 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2012 | 14 | 0.420 |
Why?
|
| Peritoneum | 1 | 2012 | 27 | 0.420 |
Why?
|
| Peritoneal Neoplasms | 1 | 2012 | 23 | 0.420 |
Why?
|
| Arrestins | 1 | 2013 | 92 | 0.410 |
Why?
|
| Signal Transduction | 7 | 2008 | 2689 | 0.410 |
Why?
|
| Mycobacterium | 1 | 2011 | 12 | 0.400 |
Why?
|
| Potassium | 4 | 2022 | 168 | 0.400 |
Why?
|
| Mycobacterium Infections | 1 | 2011 | 13 | 0.400 |
Why?
|
| Kidney Glomerulus | 4 | 2003 | 155 | 0.390 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 95 | 0.380 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 161 | 0.380 |
Why?
|
| NF-kappa B | 1 | 2013 | 432 | 0.370 |
Why?
|
| Humans | 30 | 2022 | 68618 | 0.370 |
Why?
|
| Down-Regulation | 3 | 2004 | 447 | 0.370 |
Why?
|
| Pasteurella Infections | 1 | 2010 | 5 | 0.360 |
Why?
|
| Pasteurella multocida | 1 | 2010 | 6 | 0.360 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 425 | 0.360 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2010 | 34 | 0.350 |
Why?
|
| Inositol Phosphates | 6 | 2005 | 28 | 0.350 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2009 | 31 | 0.330 |
Why?
|
| Receptors, Vasopressin | 1 | 2008 | 5 | 0.330 |
Why?
|
| Dithiothreitol | 1 | 2008 | 17 | 0.330 |
Why?
|
| Antioxidants | 2 | 2008 | 304 | 0.330 |
Why?
|
| Vasoconstrictor Agents | 2 | 2008 | 107 | 0.320 |
Why?
|
| Biopsy | 1 | 2010 | 540 | 0.310 |
Why?
|
| Male | 28 | 2022 | 37321 | 0.300 |
Why?
|
| Ambulatory Care | 2 | 2022 | 340 | 0.290 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 5 | 0.290 |
Why?
|
| Rats, Inbred WF | 4 | 2003 | 14 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1026 | 0.280 |
Why?
|
| Adrenal Cortex Hormones | 2 | 1999 | 186 | 0.270 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 778 | 0.270 |
Why?
|
| Corynebacterium Infections | 1 | 2005 | 1 | 0.270 |
Why?
|
| Rhizobium | 1 | 2005 | 1 | 0.270 |
Why?
|
| Corynebacterium | 1 | 2005 | 2 | 0.270 |
Why?
|
| Pseudomonas | 1 | 2005 | 8 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2007 | 617 | 0.260 |
Why?
|
| Receptors, Thromboxane | 5 | 1998 | 122 | 0.260 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 148 | 0.250 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2005 | 62 | 0.250 |
Why?
|
| Middle Aged | 13 | 2022 | 21147 | 0.250 |
Why?
|
| Pseudomonas Infections | 1 | 2005 | 83 | 0.250 |
Why?
|
| Aorta, Thoracic | 4 | 2013 | 211 | 0.240 |
Why?
|
| Radioligand Assay | 7 | 2008 | 109 | 0.240 |
Why?
|
| Female | 14 | 2022 | 38074 | 0.230 |
Why?
|
| Adult | 10 | 2022 | 21403 | 0.230 |
Why?
|
| Ferric Compounds | 1 | 2004 | 45 | 0.230 |
Why?
|
| Aged | 7 | 2022 | 14862 | 0.210 |
Why?
|
| Hypertension | 7 | 1999 | 1535 | 0.210 |
Why?
|
| Desoxycorticosterone | 3 | 2000 | 41 | 0.210 |
Why?
|
| Consciousness Disorders | 1 | 2002 | 7 | 0.210 |
Why?
|
| Hyperammonemia | 1 | 2002 | 4 | 0.210 |
Why?
|
| Carnitine | 1 | 2002 | 17 | 0.210 |
Why?
|
| Acetylcysteine | 1 | 2005 | 296 | 0.200 |
Why?
|
| Outpatients | 1 | 2022 | 127 | 0.200 |
Why?
|
| Retrospective Studies | 4 | 2022 | 7277 | 0.200 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 1997 | 64 | 0.200 |
Why?
|
| Mineralocorticoids | 2 | 1999 | 9 | 0.190 |
Why?
|
| Dialysis Solutions | 1 | 2000 | 5 | 0.190 |
Why?
|
| Hepatitis C | 1 | 2002 | 114 | 0.190 |
Why?
|
| Up-Regulation | 5 | 2010 | 682 | 0.180 |
Why?
|
| Immunoblotting | 4 | 2008 | 254 | 0.180 |
Why?
|
| South Carolina | 3 | 2016 | 2752 | 0.180 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 1997 | 84 | 0.180 |
Why?
|
| Cell Nucleus | 3 | 2008 | 305 | 0.180 |
Why?
|
| Sodium | 1 | 2000 | 161 | 0.170 |
Why?
|
| Serum Albumin | 1 | 1999 | 104 | 0.160 |
Why?
|
| Dexamethasone | 2 | 1997 | 150 | 0.160 |
Why?
|
| Hypotension | 1 | 1999 | 74 | 0.160 |
Why?
|
| Nephrotic Syndrome | 1 | 1999 | 61 | 0.160 |
Why?
|
| Incidence | 1 | 2022 | 1603 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 250 | 0.160 |
Why?
|
| Enzyme Activation | 7 | 2009 | 791 | 0.150 |
Why?
|
| Tyrosine | 2 | 1999 | 196 | 0.150 |
Why?
|
| Endothelium, Vascular | 2 | 1996 | 371 | 0.150 |
Why?
|
| Disulfides | 2 | 2008 | 40 | 0.140 |
Why?
|
| Calcium | 5 | 2008 | 929 | 0.140 |
Why?
|
| Sodium, Dietary | 1 | 1997 | 31 | 0.140 |
Why?
|
| Terrorism | 1 | 2017 | 21 | 0.140 |
Why?
|
| India | 1 | 2017 | 41 | 0.140 |
Why?
|
| Cell Line | 3 | 2009 | 1752 | 0.140 |
Why?
|
| Police | 1 | 2017 | 34 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 200 | 0.140 |
Why?
|
| Carbenoxolone | 1 | 1996 | 4 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2017 | 127 | 0.140 |
Why?
|
| Research Personnel | 1 | 2017 | 83 | 0.130 |
Why?
|
| Time Factors | 5 | 2010 | 4655 | 0.130 |
Why?
|
| Iron-Dextran Complex | 1 | 1996 | 3 | 0.130 |
Why?
|
| Ascitic Fluid | 1 | 1996 | 22 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 127 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 43 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 201 | 0.130 |
Why?
|
| Corticosterone | 1 | 1995 | 51 | 0.130 |
Why?
|
| Calcitriol | 1 | 2016 | 106 | 0.130 |
Why?
|
| Universities | 1 | 2017 | 191 | 0.130 |
Why?
|
| Erythropoietin | 1 | 2016 | 96 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 91 | 0.130 |
Why?
|
| Kinetics | 4 | 2005 | 1047 | 0.130 |
Why?
|
| Home Care Services | 1 | 2016 | 84 | 0.130 |
Why?
|
| Lithium | 1 | 1995 | 76 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.130 |
Why?
|
| Heparin | 1 | 2016 | 205 | 0.120 |
Why?
|
| Thiazolidines | 1 | 2014 | 23 | 0.120 |
Why?
|
| Self Administration | 1 | 2016 | 419 | 0.120 |
Why?
|
| Protein Transport | 1 | 2014 | 280 | 0.120 |
Why?
|
| Rats, Inbred Strains | 6 | 1997 | 532 | 0.120 |
Why?
|
| Mitogens | 2 | 2004 | 45 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 141 | 0.110 |
Why?
|
| Rats, Wistar | 3 | 2000 | 371 | 0.110 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2003 | 43 | 0.110 |
Why?
|
| beta-Arrestin 1 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2016 | 356 | 0.110 |
Why?
|
| beta-Arrestins | 1 | 2013 | 80 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2016 | 322 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 1993 | 94 | 0.110 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.100 |
Why?
|
| Fatty Acids | 1 | 1993 | 222 | 0.100 |
Why?
|
| Adrenalectomy | 2 | 2003 | 17 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 306 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 411 | 0.100 |
Why?
|
| Mesenteric Arteries | 2 | 1990 | 29 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 261 | 0.090 |
Why?
|
| Protein Kinase C | 5 | 2003 | 270 | 0.090 |
Why?
|
| Nephrectomy | 2 | 2003 | 103 | 0.090 |
Why?
|
| In Vitro Techniques | 3 | 1996 | 765 | 0.090 |
Why?
|
| Cell Membrane | 3 | 2005 | 525 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 442 | 0.090 |
Why?
|
| Creatinine | 1 | 2010 | 243 | 0.090 |
Why?
|
| Biological Transport | 3 | 2000 | 210 | 0.080 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 2009 | 5 | 0.080 |
Why?
|
| Wasp Venoms | 1 | 2009 | 8 | 0.080 |
Why?
|
| beta 2-Microglobulin | 1 | 1989 | 15 | 0.080 |
Why?
|
| Phosphorylation | 6 | 2004 | 1200 | 0.080 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1989 | 13 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 376 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.080 |
Why?
|
| Diuresis | 1 | 2008 | 20 | 0.080 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2008 | 15 | 0.080 |
Why?
|
| Urine | 1 | 2008 | 47 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2004 | 4848 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 134 | 0.080 |
Why?
|
| Amyloidosis | 1 | 1989 | 48 | 0.080 |
Why?
|
| Amyloid | 1 | 1989 | 39 | 0.080 |
Why?
|
| Reference Values | 2 | 2000 | 579 | 0.080 |
Why?
|
| Cell Division | 3 | 1997 | 541 | 0.080 |
Why?
|
| Protein Binding | 2 | 2005 | 1027 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2010 | 328 | 0.080 |
Why?
|
| ErbB Receptors | 3 | 2004 | 239 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 146 | 0.080 |
Why?
|
| Arsenicals | 1 | 2008 | 8 | 0.080 |
Why?
|
| Bacteremia | 1 | 2010 | 155 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 175 | 0.080 |
Why?
|
| Hypercalcemia | 1 | 1988 | 34 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2003 | 195 | 0.080 |
Why?
|
| Renal Veins | 1 | 1987 | 18 | 0.070 |
Why?
|
| Renal Artery | 1 | 1987 | 29 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 150 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 147 | 0.070 |
Why?
|
| Arteriovenous Malformations | 1 | 1987 | 34 | 0.070 |
Why?
|
| Sepsis | 1 | 2010 | 233 | 0.070 |
Why?
|
| Drug Interactions | 3 | 2003 | 289 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2004 | 659 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 55 | 0.070 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2006 | 42 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1465 | 0.070 |
Why?
|
| Calmodulin | 2 | 2003 | 53 | 0.070 |
Why?
|
| Peptides | 1 | 2009 | 455 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 322 | 0.070 |
Why?
|
| Soil Microbiology | 1 | 2005 | 21 | 0.070 |
Why?
|
| Abscess | 1 | 2005 | 37 | 0.070 |
Why?
|
| Phytosterols | 1 | 2005 | 8 | 0.070 |
Why?
|
| Receptors, Bradykinin | 2 | 2003 | 50 | 0.060 |
Why?
|
| Thioctic Acid | 1 | 2005 | 6 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2005 | 47 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 1330 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2005 | 164 | 0.060 |
Why?
|
| Vitamin E | 1 | 2005 | 55 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1999 | 136 | 0.060 |
Why?
|
| Phosphates | 1 | 2005 | 72 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 1996 | 163 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 122 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1851 | 0.060 |
Why?
|
| Cytochalasin D | 1 | 2004 | 10 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2004 | 31 | 0.060 |
Why?
|
| Tyrphostins | 1 | 2004 | 13 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 1988 | 286 | 0.060 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2005 | 112 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 120 | 0.060 |
Why?
|
| Hemodynamics | 1 | 1987 | 705 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 161 | 0.060 |
Why?
|
| Quinazolines | 1 | 2004 | 70 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2010 | 2007 | 0.060 |
Why?
|
| Serine | 1 | 2004 | 99 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2004 | 75 | 0.060 |
Why?
|
| Compliance | 1 | 2003 | 26 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 341 | 0.060 |
Why?
|
| Drug Synergism | 2 | 1995 | 260 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2003 | 133 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 317 | 0.060 |
Why?
|
| Oxygen | 1 | 2005 | 386 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 334 | 0.050 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2003 | 3 | 0.050 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 2 | 1993 | 52 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 948 | 0.050 |
Why?
|
| Anemia | 1 | 2004 | 104 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 1997 | 1664 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 499 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 62 | 0.050 |
Why?
|
| Bradykinin | 2 | 2003 | 157 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 214 | 0.050 |
Why?
|
| Mutation | 1 | 2006 | 1213 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.050 |
Why?
|
| Fibrosis | 1 | 2003 | 371 | 0.050 |
Why?
|
| Renal Plasma Flow | 1 | 2000 | 1 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 1999 | 2550 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2003 | 223 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2000 | 20 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 63 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 57 | 0.050 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2000 | 242 | 0.040 |
Why?
|
| Probability | 1 | 2000 | 245 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2002 | 7029 | 0.040 |
Why?
|
| Mannitol | 1 | 1999 | 25 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 107 | 0.040 |
Why?
|
| Serotonin | 3 | 2004 | 144 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 1999 | 114 | 0.040 |
Why?
|
| Histidine | 1 | 1998 | 17 | 0.040 |
Why?
|
| Cost Savings | 1 | 1999 | 110 | 0.040 |
Why?
|
| Organ Size | 1 | 1999 | 242 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 306 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1999 | 152 | 0.040 |
Why?
|
| Albuminuria | 1 | 1999 | 171 | 0.040 |
Why?
|
| Potassium Deficiency | 2 | 1988 | 2 | 0.040 |
Why?
|
| Hypertension, Renovascular | 2 | 1989 | 47 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 1999 | 567 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1997 | 25 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1997 | 45 | 0.040 |
Why?
|
| Genes, jun | 1 | 1997 | 13 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1997 | 48 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 1999 | 222 | 0.040 |
Why?
|
| Culture Media | 2 | 2003 | 155 | 0.040 |
Why?
|
| Drug Resistance | 1 | 1997 | 223 | 0.040 |
Why?
|
| Chloroquine | 1 | 1996 | 21 | 0.030 |
Why?
|
| Methionine | 1 | 1996 | 36 | 0.030 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 1993 | 41 | 0.030 |
Why?
|
| Colchicine | 1 | 1996 | 48 | 0.030 |
Why?
|
| Species Specificity | 1 | 1997 | 303 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1999 | 1040 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1996 | 61 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds | 2 | 1995 | 29 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 1753 | 0.030 |
Why?
|
| Oleic Acids | 1 | 1995 | 40 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1998 | 13 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 215 | 0.030 |
Why?
|
| Transfection | 1 | 1997 | 782 | 0.030 |
Why?
|
| Diglycerides | 1 | 1995 | 49 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 86 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 562 | 0.030 |
Why?
|
| Cytoplasm | 2 | 1999 | 155 | 0.030 |
Why?
|
| Body Weight | 1 | 1997 | 554 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1995 | 210 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1995 | 52 | 0.030 |
Why?
|
| Steroids | 1 | 1994 | 84 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1997 | 786 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 88 | 0.030 |
Why?
|
| Leucine | 1 | 1993 | 41 | 0.030 |
Why?
|
| Hospitalization | 1 | 1999 | 978 | 0.030 |
Why?
|
| Enalapril | 2 | 1990 | 86 | 0.030 |
Why?
|
| Iloprost | 1 | 1992 | 4 | 0.030 |
Why?
|
| Infant | 1 | 1999 | 2891 | 0.030 |
Why?
|
| Rats, Inbred SHR | 3 | 2005 | 95 | 0.030 |
Why?
|
| Receptors, Prostaglandin | 1 | 1992 | 74 | 0.030 |
Why?
|
| Child, Preschool | 1 | 1999 | 3187 | 0.030 |
Why?
|
| Prospective Studies | 1 | 1999 | 3705 | 0.020 |
Why?
|
| Antihypertensive Agents | 2 | 2000 | 498 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1992 | 284 | 0.020 |
Why?
|
| Nifedipine | 1 | 1990 | 40 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1989 | 41 | 0.020 |
Why?
|
| CHO Cells | 2 | 2000 | 161 | 0.020 |
Why?
|
| Cricetinae | 2 | 2000 | 262 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2004 | 954 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 1989 | 23 | 0.020 |
Why?
|
| Bone Diseases | 1 | 1989 | 20 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1989 | 41 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 1991 | 344 | 0.020 |
Why?
|
| COS Cells | 2 | 1998 | 155 | 0.020 |
Why?
|
| Child | 1 | 1999 | 6405 | 0.020 |
Why?
|
| Calcium Carbonate | 1 | 1988 | 7 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 1998 | 251 | 0.020 |
Why?
|
| Electrolytes | 1 | 1988 | 47 | 0.020 |
Why?
|
| Iodine Radioisotopes | 2 | 2000 | 119 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1991 | 232 | 0.020 |
Why?
|
| Cyclic AMP | 2 | 1998 | 223 | 0.020 |
Why?
|
| Type C Phospholipases | 2 | 2003 | 67 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1987 | 83 | 0.020 |
Why?
|
| Adolescent | 1 | 1999 | 8912 | 0.020 |
Why?
|
| Radiography | 1 | 1987 | 572 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1998 | 165 | 0.020 |
Why?
|
| Sitosterols | 1 | 2005 | 8 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2005 | 18 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 7 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2004 | 37 | 0.010 |
Why?
|
| Androstadienes | 1 | 2004 | 41 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2004 | 36 | 0.010 |
Why?
|
| Diet | 1 | 1987 | 514 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 60 | 0.010 |
Why?
|
| Fluorometry | 1 | 2003 | 7 | 0.010 |
Why?
|
| Flavonoids | 1 | 2004 | 109 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2003 | 40 | 0.010 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2003 | 15 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2003 | 13 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2003 | 26 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2003 | 47 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2003 | 75 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 618 | 0.010 |
Why?
|
| ras Proteins | 1 | 2003 | 102 | 0.010 |
Why?
|
| Pregnancy | 1 | 1988 | 2334 | 0.010 |
Why?
|
| Platelet Aggregation | 2 | 1992 | 127 | 0.010 |
Why?
|
| Quinolinium Compounds | 1 | 2000 | 3 | 0.010 |
Why?
|
| Losartan | 1 | 2000 | 45 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 597 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 191 | 0.010 |
Why?
|
| Thiazoles | 1 | 2000 | 95 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 981 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1999 | 30 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 337 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 60 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 191 | 0.010 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1998 | 66 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 67 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 272 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1998 | 88 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 165 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 231 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 357 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 208 | 0.010 |
Why?
|
| RNA | 1 | 1998 | 171 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 492 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 1083 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1998 | 306 | 0.010 |
Why?
|
| Oleic Acid | 1 | 1995 | 40 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1447 | 0.010 |
Why?
|
| Vasodilation | 1 | 1995 | 85 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1995 | 13 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1995 | 139 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 509 | 0.010 |
Why?
|
| Testosterone | 1 | 1995 | 96 | 0.010 |
Why?
|
| Cattle | 1 | 1995 | 475 | 0.010 |
Why?
|
| Estradiol | 1 | 1995 | 176 | 0.010 |
Why?
|
| Sex Factors | 1 | 1995 | 1266 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 8474 | 0.010 |
Why?
|
| Binding Sites | 1 | 1992 | 631 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1991 | 190 | 0.010 |
Why?
|
| Reserpine | 1 | 1989 | 24 | 0.010 |
Why?
|
| Hydralazine | 1 | 1989 | 12 | 0.010 |
Why?
|
| Captopril | 1 | 1989 | 22 | 0.010 |
Why?
|
| Hydrochlorothiazide | 1 | 1989 | 15 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1989 | 49 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1991 | 714 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 1988 | 79 | 0.000 |
Why?
|
| Survival Rate | 1 | 1991 | 1056 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1988 | 276 | 0.000 |
Why?
|
| Comorbidity | 1 | 1991 | 1426 | 0.000 |
Why?
|
| Prognosis | 1 | 1991 | 2093 | 0.000 |
Why?
|